Transcutaneous delivery of disease specific PI3K/Akt/mTOR inhibitor based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies
R. keshari, R. Bagale, S. Rath, A. De, R. Banerjee, S. Sen, R. Srivastava
This paper develops a hybrid nanoparticle-hydrogel system for psoriasis treatment, showing improved drug delivery and reduced PASI scores in vivo.
bioRxiv · Jun 17, 2024Pharmacology & Toxicology